CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: bosentan
Accession: CHEBI:51450
browse the term
Definition: A pyrimidine that has formula C27H29N5O6S.
Synonyms: exact_synonym: 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
related_synonym: 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide; Formula=C27H29N5O6S; InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32); InChIKey=GJPICJJJRGTNOD-UHFFFAOYSA-N; SMILES=COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1; bosentanum; p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
xref: CAS:147536-97-8; DrugBank:DB00559; Drug_Central:392; KEGG:D07538; LINCS:LSM-5825
xref_mesh: MESH:C086232
xref: Patent:US2986573; Wikipedia:Bosentan
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions decreases expression
EXP ISO
bosentan metabolite results in decreased activity of ABCB11 protein; bosentan results in decreased activity of ABCB11 protein bosentan inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] bosentan results in decreased expression of ABCB11 mRNA Bosentan results in decreased expression of ABCB11 mRNA
CTD
PMID:11309550 PMID:15465654 PMID:15509663 PMID:20829430 PMID:23956101 PMID:24014644 PMID:27765674 PMID:29761207 More...
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression
ISO
bosentan results in decreased expression of ABCB1 mRNA
CTD
PMID:28369585
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
decreases expression
ISO
Bosentan results in decreased expression of ABCB4 mRNA
CTD
PMID:29761207
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression decreases expression
EXP ISO
bosentan results in increased expression of ABCC2 mRNA bosentan results in decreased expression of ABCC2 mRNA Bosentan results in increased expression of ABCC2 mRNA
CTD
PMID:27765674 PMID:28369585 PMID:29761207
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression decreases expression
EXP ISO
bosentan results in increased expression of ABCC3 mRNA bosentan results in decreased expression of ABCC3 mRNA
CTD
PMID:27765674 PMID:28369585
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
increases expression
EXP
bosentan results in increased expression of ABCC4 mRNA
CTD
PMID:27765674
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression affects expression
EXP ISO
bosentan results in increased expression of ABCG5 mRNA Bosentan affects the expression of ABCG5 mRNA
CTD
PMID:27765674 PMID:29761207
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
increases expression
EXP
bosentan results in increased expression of ABCG8 mRNA
CTD
PMID:27765674
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
ISO
Bosentan results in decreased expression of ADH1C mRNA; Bosentan results in decreased expression of ADH1C protein
CTD
PMID:29761207
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
ISO
Bosentan results in decreased expression of ADH4 mRNA; Bosentan results in decreased expression of ADH4 protein
CTD
PMID:29761207
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
bosentan inhibits the reaction [EDN1 protein results in increased expression of ADRB2 mRNA]
CTD
PMID:22483689
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Aldh8a1
aldehyde dehydrogenase 8 family, member A1
affects expression
ISO
Bosentan affects the expression of ALDH8A1 mRNA
CTD
PMID:29761207
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
ISO
Bosentan results in decreased expression of ALDOB mRNA; Bosentan results in decreased expression of ALDOB protein
CTD
PMID:29761207
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Ascl1
achaete-scute family bHLH transcription factor 1
affects expression
ISO
Bosentan affects the expression of ASCL1 mRNA
CTD
PMID:29761207
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
bosentan inhibits the reaction [Doxorubicin results in increased expression of BAX protein]
CTD
PMID:17974986
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
C3h15orf48
similar to human chromosome 15 open reading frame 48
affects expression
ISO
Bosentan affects the expression of C15ORF48 mRNA
CTD
PMID:29761207
NCBI chr 3:109,719,952...109,723,505
Ensembl chr 3:109,719,897...109,724,006 Ensembl chr 3:109,719,897...109,724,006
G
C9
complement C9
affects expression
ISO
Bosentan affects the expression of C9 mRNA
CTD
PMID:29761207
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
G
Car12
carbonic anhydrase 12
affects expression
ISO
Bosentan affects the expression of CA12 mRNA
CTD
PMID:29761207
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Casp3
caspase 3
multiple interactions
EXP
Bosentan inhibits the reaction [Fluorouracil results in increased cleavage of CASP3 protein]
CTD
PMID:34800596
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
decreases expression
ISO
Bosentan results in decreased expression of CAT mRNA
CTD
PMID:29761207
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
bosentan results in decreased expression of COL1A2 protein
CTD
PMID:11729239
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
ISO
Bosentan results in decreased expression of CPS1 mRNA; Bosentan results in decreased expression of CPS1 protein
CTD
PMID:29761207
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression multiple interactions
ISO
bosentan results in decreased expression of CXADR mRNA; bosentan results in decreased expression of CXADR protein EDN1 protein inhibits the reaction [bosentan results in decreased expression of CXADR mRNA]
CTD
PMID:20392896
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression
ISO
Bosentan results in increased expression of CYP2B6 mRNA
CTD
PMID:18332078 PMID:29761207
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
affects expression
ISO
Bosentan affects the expression of CYP3A43 mRNA
CTD
PMID:29761207
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Bosentan results in increased expression of CYP3A4 mRNA
CTD
PMID:18332078 PMID:29761207
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
ISO
Bosentan results in decreased expression of CYP7A1 mRNA
CTD
PMID:29761207
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Dclk1
doublecortin-like kinase 1
affects expression
ISO
Bosentan affects the expression of DCLK1 mRNA
CTD
PMID:29761207
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Dlx6
distal-less homeobox 6
decreases expression
ISO
bosentan results in decreased expression of DLX6 mRNA
CTD
PMID:15063187
NCBI chr 4:34,984,264...34,989,926
Ensembl chr 4:34,984,232...34,991,343
G
Edn1
endothelin 1
decreases activity multiple interactions decreases expression
EXP ISO
bosentan results in decreased activity of EDN1 protein 3,5-dibromosalicylic acid inhibits the reaction [bosentan inhibits the reaction [EDN1 protein binds to EDNRA protein]]; bosentan binds to and results in decreased activity of EDN1 protein; bosentan inhibits the reaction [EDN1 protein binds to EDNRA protein]; bosentan inhibits the reaction [Monocrotaline results in increased expression of EDN1 mRNA] bosentan inhibits the reaction [EDN1 protein results in increased expression of ADRB2 mRNA]; bosentan inhibits the reaction [Oxotremorine results in increased activity of EDN1 protein]; bosentan inhibits the reaction [TGFB1 protein results in increased activity of EDN1 protein]; EDN1 protein inhibits the reaction [bosentan results in decreased expression of CXADR mRNA] bosentan results in decreased expression of EDN1 protein
CTD
PMID:10474778 PMID:10961375 PMID:11093786 PMID:16431896 PMID:20392896 PMID:20967148 PMID:22483689 PMID:22796455 More...
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Edn3
endothelin 3
decreases activity
EXP
bosentan results in decreased activity of EDN3 protein
CTD
PMID:10961375
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
G
Ednra
endothelin receptor type A
multiple interactions
ISO EXP
bosentan binds to and results in decreased activity of EDNRA protein 3,5-dibromosalicylic acid inhibits the reaction [bosentan inhibits the reaction [EDN1 protein binds to EDNRA protein]]; bosentan binds to and results in decreased activity of EDNRA protein; bosentan inhibits the reaction [EDN1 protein binds to EDNRA protein]
CTD
PMID:11093786 PMID:15964565 PMID:16219361
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
multiple interactions
ISO
bosentan binds to and results in decreased activity of EDNRB protein
CTD
PMID:16219361
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Fabp1
fatty acid binding protein 1
decreases expression
ISO
Bosentan results in decreased expression of FABP1 mRNA; Bosentan results in decreased expression of FABP1 protein
CTD
PMID:29761207
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fn1
fibronectin 1
multiple interactions
ISO
bosentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; bosentan inhibits the reaction [Glucose results in increased expression of FN1 protein]
CTD
PMID:12388107
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
G0s2
G0/G1switch 2
affects expression
ISO
Bosentan affects the expression of G0S2 mRNA
CTD
PMID:29761207
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
affects expression
ISO
Bosentan affects the expression of G6PC1 mRNA
CTD
PMID:29761207
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gata4
GATA binding protein 4
multiple interactions affects activity
ISO EXP
bosentan inhibits the reaction [Doxorubicin results in decreased expression of GATA4 mRNA]; bosentan inhibits the reaction [Doxorubicin results in decreased expression of GATA4 protein] bosentan affects the activity of GATA4 protein
CTD
PMID:17974986 PMID:21084678
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Bosentan results in increased expression of GCLC mRNA
CTD
PMID:29761207
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
Bosentan inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of GPT protein]
CTD
PMID:33026618
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
decreases expression
ISO
Bosentan results in decreased expression of GPX1 mRNA
CTD
PMID:29761207
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gstt2
glutathione S-transferase theta 2
decreases expression
ISO
Bosentan results in decreased expression of GSTT2 mRNA
CTD
PMID:29761207
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
G
Hmox1
heme oxygenase 1
increases expression
ISO
Bosentan results in increased expression of HMOX1 mRNA
CTD
PMID:29761207
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression
ISO
Bosentan results in decreased expression of HNF4A mRNA
CTD
PMID:29761207
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
affects expression
ISO
Bosentan affects the expression of HSD3B1 mRNA
CTD
PMID:29761207
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Igf1
insulin-like growth factor 1
affects expression
ISO
Bosentan affects the expression of IGF1 mRNA
CTD
PMID:29761207
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il6
interleukin 6
increases expression
ISO
Bosentan results in increased expression of IL6 mRNA
CTD
PMID:29761207
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbe
inhibin subunit beta E
affects expression
ISO
Bosentan affects the expression of INHBE mRNA
CTD
PMID:29761207
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Kmo
kynurenine 3-monooxygenase
affects expression
ISO
Bosentan affects the expression of KMO mRNA
CTD
PMID:29761207
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Leap2
liver enriched antimicrobial peptide 2
affects expression
ISO
Bosentan affects the expression of LEAP2 mRNA
CTD
PMID:29761207
NCBI chr10:37,580,172...37,581,244
Ensembl chr10:37,577,855...37,581,244
G
Mgst1
microsomal glutathione S-transferase 1
decreases expression
ISO
Bosentan results in decreased expression of MGST1 mRNA
CTD
PMID:29761207
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mrc1
mannose receptor, C type 1
affects expression
ISO
Bosentan affects the expression of MRC1 mRNA
CTD
PMID:29761207
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Mttp
microsomal triglyceride transfer protein
decreases expression
ISO
Bosentan results in decreased expression of MTTP mRNA
CTD
PMID:29761207
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
EXP
Bosentan inhibits the reaction [Fluorouracil results in increased expression of MYD88 protein]
CTD
PMID:34800596
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Myh7
myosin heavy chain 7
multiple interactions
ISO
Bosentan inhibits the reaction [MYH7 gene mutant form results in increased expression of NPPB protein]
CTD
PMID:29741611
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
G
Nfix
nuclear factor I X
decreases expression
ISO
Bosentan results in decreased expression of NFIX mRNA
CTD
PMID:29761207
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nos3
nitric oxide synthase 3
multiple interactions
EXP
Bosentan inhibits the reaction [Fluorouracil results in decreased expression of NOS3 protein]
CTD
PMID:34800596
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox4
NADPH oxidase 4
decreases expression
ISO
Bosentan results in decreased expression of NOX4 mRNA
CTD
PMID:29761207
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Nppb
natriuretic peptide B
multiple interactions
ISO
Bosentan inhibits the reaction [MYH7 gene mutant form results in increased expression of NPPB protein]
CTD
PMID:29741611
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Bosentan results in increased expression of NQO1 mRNA
CTD
PMID:29761207
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
decreases expression
ISO
Bosentan results in decreased expression of NR1H2 mRNA
CTD
PMID:29761207
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
decreases expression
ISO
Bosentan results in decreased expression of NR1H3 mRNA
CTD
PMID:29761207
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression
ISO
Bosentan results in decreased expression of NR1H4 mRNA
CTD
PMID:29761207
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
Bosentan results in decreased expression of PCK2 mRNA
CTD
PMID:29761207
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pglyrp2
peptidoglycan recognition protein 2
affects expression
ISO
Bosentan affects the expression of PGLYRP2 mRNA
CTD
PMID:29761207
NCBI chr 7:11,418,674...11,432,162
Ensembl chr 7:11,418,880...11,427,773
G
Pklr
pyruvate kinase L/R
affects expression
ISO
Bosentan affects the expression of PKLR mRNA
CTD
PMID:29761207
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Pon1
paraoxonase 1
decreases expression
ISO
Bosentan results in decreased expression of PON1 mRNA
CTD
PMID:29761207
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Por
cytochrome p450 oxidoreductase
affects expression
ISO
Bosentan affects the expression of POR mRNA
CTD
PMID:29761207
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
Bosentan results in decreased expression of PPARG mRNA
CTD
PMID:29761207
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
decreases expression
ISO
Bosentan results in decreased expression of PPARGC1A mRNA
CTD
PMID:29761207
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ptgis
prostaglandin I2 synthase
multiple interactions
EXP
Bosentan inhibits the reaction [Monocrotaline increases expression of Ptgis mRNA in lung]
RGD
PMID:18612919
RGD:401901264
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO EXP
bosentan inhibits the reaction [Glucose results in increased activity of RELA protein] Bosentan inhibits the reaction [Fluorouracil results in increased expression of RELA protein]
CTD
PMID:12388107 PMID:34800596
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sftpa1
surfactant protein A1
multiple interactions
EXP
Bosentan inhibits the reaction [Nitric Oxide Donors results in decreased expression of SFTPA1 mRNA]; Bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPA1 mRNA]; Bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA]
CTD
PMID:15640287
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
G
Sftpb
surfactant protein B
multiple interactions
EXP
bosentan inhibits the reaction [Nitric Oxide Donors results in decreased expression of SFTPB mRNA]; bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPB mRNA]; bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA]
CTD
PMID:15640287
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
multiple interactions
EXP
bosentan inhibits the reaction [Nitric Oxide Donors results in decreased expression of SFTPC mRNA]; bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPC mRNA]; bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA]
CTD
PMID:15640287
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP ISO
bosentan results in decreased expression of SLC10A1 mRNA Bosentan results in decreased expression of SLC10A1 mRNA
CTD
PMID:27765674 PMID:28369585 PMID:29761207
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc22a7
solute carrier family 22 member 7
affects expression
ISO
Bosentan affects the expression of SLC22A7 mRNA
CTD
PMID:29761207
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
Bosentan results in increased expression of SLC3A2 mRNA; Bosentan results in increased expression of SLC3A2 protein
CTD
PMID:29761207
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc51a
solute carrier family 51 member A
increases expression
ISO
Bosentan results in increased expression of SLC51A mRNA
CTD
PMID:29761207
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc51b
SLC51 subunit beta
increases expression
ISO
Bosentan results in increased expression of SLC51B mRNA
CTD
PMID:29761207
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slc6a1
solute carrier family 6 member 1
affects expression
ISO
Bosentan affects the expression of SLC6A1 mRNA
CTD
PMID:29761207
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Slco1c1
solute carrier organic anion transporter family, member 1c1
multiple interactions increases uptake
EXP
[biochanin A results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [hispidulin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [isoliquiritigenin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [kaempferol results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [licochalcone A results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [Luteolin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [sinensetin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan SLCO1B1 protein results in increased uptake of Bosentan
CTD
PMID:32259555
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
G
Sod1
superoxide dismutase 1
decreases expression
ISO
Bosentan results in decreased expression of SOD1 mRNA
CTD
PMID:29761207
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression
ISO
Bosentan results in increased expression of SOD2 mRNA
CTD
PMID:29761207
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sult1e1
sulfotransferase family 1E member 1
affects expression
ISO
Bosentan affects the expression of SULT1E1 mRNA
CTD
PMID:29761207
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Tat
tyrosine aminotransferase
affects expression
ISO
Bosentan affects the expression of TAT mRNA
CTD
PMID:29761207
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
bosentan inhibits the reaction [TGFB1 protein results in increased activity of EDN1 protein]
CTD
PMID:22796455
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr4
toll-like receptor 4
multiple interactions
EXP
Bosentan inhibits the reaction [Fluorouracil results in increased expression of TLR4 protein]
CTD
PMID:34800596
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions
ISO
bosentan inhibits the reaction [Doxorubicin results in increased expression of TNF protein]
CTD
PMID:17974986
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnni1
troponin I1, slow skeletal type
multiple interactions
EXP
Bosentan inhibits the reaction [Fluorouracil results in increased expression of TNNI1 protein]
CTD
PMID:34800596
NCBI chr13:47,229,217...47,241,640
Ensembl chr13:47,229,216...47,241,644
G
Txn2
thioredoxin 2
decreases expression
ISO
Bosentan results in decreased expression of TXN2 mRNA
CTD
PMID:29761207
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Bosentan results in increased expression of TXNRD1 mRNA
CTD
PMID:29761207
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases expression
ISO
Bosentan results in decreased expression of UGT1A6 mRNA
CTD
PMID:29761207
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Vnn1
vanin 1
affects expression
ISO
Bosentan affects the expression of VNN1 mRNA
CTD
PMID:29761207
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Xdh
xanthine dehydrogenase
decreases expression
ISO
Bosentan results in decreased expression of XDH mRNA
CTD
PMID:29761207
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all